1. American Cancer Society: The global economic cost of cancer. American Cancer Society, Atlanta 2010. Available at http://www.cancer.org/acs/groups/content/@internationalaffairs/documents/document/acspc-026203.pdf . Accessed February 22, 2013.
2. Rockson SG, Rivera KK. Estimating the population burden of lymphedema. Ann N Y Acad Sci. 2008;1131:147–54.
3. • Armer JM, Stewart BR. Post-breast cancer lymphedema: incidence increases from 12 to 30 to 60 months. Lymphology. 2010;43:118–27. This study followed survivors’ limb volume change from pre-surgery through 57 months post-surgery using the four most commonly cited diagnostic criteria (2 cm circumferential change, 200 mL perometry LVC, 10 % perometry LVC, and signs/symptoms) and found that the 2 cm criterion is the most liberal definition of LE, followed by the 200 mL perometry criterion.
4. Földi M, Földi E, Kubik S. In Textbook of lymphology: for physicians and lymphedema therapists. Urban and Fisher: San Francisco, CA; 2003.
5. Hayes S, Di Sipio T, Rye S, et al. Prevalence and prognostic significance of secondary lymphedema following breast cancer. Lymphat Res Biol. 2011;9(3):135–41.